EP2878297
Meðul til að meðhöndla eða fyrirbyggja trefjunarsjúkdóma
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.12.2005EP published:
25.3.2020EP application number:
14190398.9
EP translation filed:
15.6.2020Grant published:
15.7.2020EPO information:
European Patent Register
Max expiry date:
20.12.2025Expiry date:
20.12.2025
Title:
Medicaments for the treatment or prevention of fibrotic diseases
Timeline
Today
21.12.2005EP application
25.3.2020EP Publication
15.6.2020Translation submitted
15.7.2020Registration published
20.12.2025Expires
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Name:
Boehringer Ingelheim Pharma GmbH & Co. KGAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
Park, JohnAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
Heckel, ArminAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
Grauert, MatthiasAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
Dahmann, GeorgAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
Brandl, TrixiAddress:
4123 Allschwil, CH
Name:
Chaudhary, NveedAddress:
2000 Neuchatel, CH
Name:
Roth, GeraldAddress:
55216 INGELHEIM AM RHEIN, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
04030770Date:
24.12.2004Country:
EP
Classification
Categories:
A61K 31/404, A61K 31/44, A61K 31/445, A61K 31/495, A61P 11/00, A61P 17/00, A61P 17/02, A61P 43/00, C07D 401/12, A61K 31/4178, C07D 403/12, A61K 45/06, A61K 31/5377, A61K 31/454, A61K 31/496, A61K 31/4045, A61K 31/551, C07D 209/34, C07D 295/155, C07D 295/215
Annual fees
Number
Paid
Expires
Payer
Number: 16
Paid: 15.12.2020
Expires: 20.12.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 17
Paid: 10.12.2021
Expires: 20.12.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 18
Paid: 13.12.2022
Expires: 20.12.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 19
Paid: 12.12.2023
Expires: 20.12.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 20
Paid: 10.12.2024
Expires: 20.12.2025
Payer: G.H. Sigurgeirsson ehf.